Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.71) by 23.94 percent. This is a 53.85 percent increase over losses of $(1.17) per share from the same period last year. The company reported quarterly sales of $8.213 million which missed the analyst consensus estimate of $9.266 million by 11.36 percent. This is a 12.80 percent decrease over sales of $9.419 million the same period last year.